For hematological diseases, the expression levels of TRH in patients with t (8;21), inv (16), and t (15;17) were higher than those in patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), and myelodysplastic syndrome (MDS) (Figure S1a). The gene discussed is TRH; the disease is hematologic disorder.